Healthcare company Nuvo Pharmaceuticals Inc (TSX:NRI) revealed on Wednesday the election of Jesse Ledger as its president & chief executive officer.

Prior to the promotion, Ledger has served as president of the company, which he joined in April of 2015.

In the new CEO position, Ledger succeeds the company's outgoing CEO John London, who has been appointed as the executive chairman and will continue to serve on its board of directors. Additionally, Dan Chicoine, previous chairman, will continue as a member of the board.

Earlier in his career, Ledger was employed as vice president of Business Development and International Business at Tribute Pharmaceuticals Canada.